Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression

By Chi K.N.   Wallis A.E.   Lee C.H.   de Menezes D.L.   Sartor J.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 199-212

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction

By Flores M.  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 917-928

Springer Publishing Company

Access to resources Recommend Favorite

Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triplenegative breast cancer cells

By Lee Jaehyung   Gollahon Lauren  

International Journal of Oncology, Vol. 42, Iss. 3, 2013-03 ,pp. : 839-847

Spandidos Publications

Access to resources Recommend Favorite

Effects of deficiency in p53 or bcl-2 on the sensitivity of clonogenic cells in the small intestine to low dose-rate irradiation

By Hendry J. H.   Broadbent D. A.   Roberts S. A.   Potten C. S.  

International Journal of Radiation Biology, Vol. 76, Iss. 4, 2000-04 ,pp. : 559-565

Informa Healthcare

Access to resources Recommend Favorite

Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: ^{31}P and ^{13}C nuclear magnetic resonance studies

By Vivi A.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 15-25

Springer Publishing Company

Access to resources Recommend Favorite